Global Super-disintegrant Market Size By Type (Natural Super-disintegrant, Synthetic Super-disintegrant), By Application (Tablets, Capsules), By Region, And Segment Forecasts, 2023 to 2032

The Global Super-disintegrant Market was valued at USD 415.6 million in 2023 and is projected to reach USD 735.9 million by 2031, growing at a CAGR of 7.3% during the forecast period (2023–2031). Super-disintegrants are critical excipients in tablet formulations, enhancing the dissolution and bioavailability of active pharmaceutical ingredients (APIs). The growing demand for fast-disintegrating drug delivery systems and the increasing geriatric population globally are key factors fueling the market's growth.

Pharmaceutical companies are actively developing orally disintegrating tablets (ODTs) to improve patient compliance, particularly for pediatric and geriatric populations. Additionally, rising investments in R&D activities, expansion in emerging markets, and regulatory support for generic drug production are creating new opportunities for market participants.

Drivers:

1. Growing Demand for Orally Disintegrating Tablets (ODTs):

ODTs offer enhanced patient compliance, especially for populations with swallowing difficulties. The trend toward convenient drug delivery solutions is significantly increasing the utilization of super-disintegrants.

2. Pharmaceutical Industry Expansion:

Global growth in the pharmaceutical sector, particularly in emerging economies, is boosting demand for efficient excipients that ensure rapid tablet disintegration, promoting faster onset of action.

3. Rising Prevalence of Chronic Diseases:

Conditions such as cardiovascular diseases, neurological disorders, and gastrointestinal issues often require immediate drug action, increasing the adoption of fast-acting tablet formulations enabled by super-disintegrants.

Restraints:

1. High Cost of Specialty Super-disintegrants:

Despite their superior performance, specialty super-disintegrants like crospovidone and sodium starch glycolate are more expensive than traditional disintegrants, limiting adoption in cost-sensitive markets.

2. Stringent Regulatory Requirements:

Regulatory complexities and the need for extensive documentation and clinical validation can delay product launches, particularly for novel drug formulations incorporating new excipients.

Opportunity:

1. Technological Advancements in Drug Formulation:

Advances in excipient engineering and drug delivery systems are opening up new possibilities for high-efficiency, multi-functional super-disintegrants.

2. Growth in Generic Drug Manufacturing:

As patents for branded drugs expire, the surge in generic drug production, especially in developing nations, is driving super-disintegrant demand to meet cost and efficiency criteria.

3. Expansion in Emerging Markets:

Increased healthcare access and pharmaceutical manufacturing capacity in Asia-Pacific and Latin America offer strong growth potential for super-disintegrant suppliers.

Market by System Type Insights:

By type, crospovidone dominated the global super-disintegrant market in 2023, driven by its high water-wicking and swelling capacity. Crospovidone’s effectiveness across a wide pH range and its compatibility with a variety of APIs make it the most preferred choice for formulating ODTs and rapidly disintegrating tablets.

Meanwhile, sodium starch glycolate is expected to witness the fastest growth rate during the forecast period. Its cost-efficiency and excellent swelling properties make it ideal for large-scale production of generic drugs.

Market by End-use Insights:

The pharmaceutical manufacturers segment accounted for the largest share in 2023, representing more than 70% of global consumption. The increasing number of prescription and over-the-counter tablets produced using high-performance disintegrants is bolstering this segment.

The contract manufacturing organizations (CMOs) segment is also growing significantly, as more pharmaceutical brands outsource their tablet formulation processes to third-party manufacturers that demand high-efficiency excipients to ensure quality and consistency.

Market by Regional Insights:

North America led the global super-disintegrant market in 2023, owing to its robust pharmaceutical industry, high R&D investment, and strong regulatory framework. The presence of major players and the high rate of adoption of innovative drug delivery systems contribute to the region's dominance.

Asia-Pacific is projected to exhibit the highest growth rate during the forecast period, fueled by expanding generic drug production, increasing healthcare expenditure, and favorable government policies supporting pharmaceutical manufacturing in countries like India and China.

Competitive Scenario:

Key players operating in the global super-disintegrant market include BASF SE, Ashland Global Holdings Inc., DFE Pharma, JRS Pharma, Roquette Frères, The Dow Chemical Company, FMC Corporation, and Asahi Kasei Corporation. These companies are focusing on strategic partnerships, capacity expansions, and product innovation to enhance their competitive edge.

Key Developments:

In 2024, BASF SE introduced a new high-performance super-disintegrant targeting fast-dissolving formulations for the pediatric drug market.

Roquette Frères expanded its excipient manufacturing facility in India in 2023 to meet growing demand in Asia-Pacific.

Ashland launched a reformulated version of its crospovidone line in 2022 with enhanced flowability and compressibility features for high-speed tablet production.

Scope of Work – Global Super-disintegrant Market

FAQs

1) What is the current market size of the Global Super-disintegrant Market?

The Global Super-disintegrant Market was valued at USD 415.6 million in 2023.

2) What is the major growth driver of the Global Super-disintegrant Market?

The growing demand for orally disintegrating tablets (ODTs) is the major growth driver.

3) Which is the largest region during the forecast period in the Global Super-disintegrant Market?

North America is expected to dominate the market during the forecast period.

4) Which segment accounted for the largest market share in the Global Super-disintegrant Market?

The Crospovidone segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Super-disintegrant Market?

Key players include BASF SE, Ashland Global Holdings Inc., DFE Pharma, Roquette Frères, and JRS Pharma.